Detalhe da pesquisa
1.
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma.
CA Cancer J Clin
; 72(5): 454-489, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708940
2.
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.
Oncologist
; 27(12): 1041-1047, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35979929
3.
PD-Loma: a cancer entity with a shared sensitivity to the PD-1/PD-L1 pathway blockade.
Br J Cancer
; 120(1): 3-5, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413824
4.
Impact of sarcopenia indexes on survival and severe immune acute toxicity in metastatic non-small cell lung cancer patients treated with PD-1 immune checkpoint inhibitors.
Clin Nutr
; 42(6): 944-953, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099986
5.
Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study.
Eur J Cancer
; 193: 113292, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37717282
6.
Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma.
Cancer Immunol Res
; 11(8): 1114-1124, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279009
7.
A Profile of Avelumab Plus Axitinib in the Treatment of Renal Cell Carcinoma.
Ther Clin Risk Manag
; 18: 683-698, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35837579
8.
Activity of Systemic Treatments After Cabozantinib Failure in Advanced Metastatic Renal Cell Carcinoma.
Clin Genitourin Cancer
; 20(1): 80-87, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688544
9.
Integrative clinical and molecular characterization of translocation renal cell carcinoma.
Cell Rep
; 38(1): 110190, 2022 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34986355
10.
Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma.
Nat Rev Clin Oncol
; 18(4): 199-214, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33437048
11.
Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study.
Pharmaceuticals (Basel)
; 14(8)2021 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34451901
12.
Neurotoxicities of novel non-steroidal anti-androgens for prostate cancer: A systematic review and meta-analysis.
Crit Rev Oncol Hematol
; 166: 103463, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34461269
13.
Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients.
Cancers (Basel)
; 13(21)2021 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771724
14.
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma.
JAMA Oncol
; 7(12): 1815-1823, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34673916
15.
Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study.
Lung Cancer
; 160: 78-83, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34461400
16.
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma.
Cancer Cell
; 39(5): 632-648.e8, 2021 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33711273
17.
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.
Nat Commun
; 12(1): 808, 2021 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33547292
18.
Immunomodulatory Roles of VEGF Pathway Inhibitors in Renal Cell Carcinoma.
Drugs
; 80(12): 1169-1181, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32601914
19.
The impact of body composition parameters on severe toxicity of nivolumab.
Eur J Cancer
; 124: 170-177, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31794927
20.
Is there an Exposure-Response Relationship for Nivolumab in Real-World NSCLC Patients?
Cancers (Basel)
; 11(11)2019 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31766292